InvestorsHub Logo
Followers 832
Posts 119978
Boards Moderated 17
Alias Born 09/05/2002

Re: tika1 post# 12

Tuesday, 01/30/2018 2:38:00 PM

Tuesday, January 30, 2018 2:38:00 PM

Post# of 68
Peak-sales potential depends on the various indications for which Entinostat is eventually approved—as well as the geographies in which it gains regulatory approval.

I don't have a specific peak-sales forecast for Entinostat; however, NKTR's enormous market-cap rise based on the early clinical data for NKTR-214 shows how valuable a drug to make "cold" tumors "hot" could potentially be.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNDX News